Research Progress in Targeted Therapy of Hepatocellular Carcinoma / 中国医学科学杂志(英文版)
Chinese Medical Sciences Journal
;
(4): 57-65, 2021.
Article
in English
| WPRIM
| ID: wpr-879310
ABSTRACT
Hepatocellular carcinoma (HCC) is one of the most common malignancies, and its treatment is limited. With the understanding of key genes and signaling pathways in the occurrence and development of HCC, targeted drugs with high selectivity and low toxicity have been developed continuously, bringing a variety of options for the treatment of advanced HCC. In this article, the research progress on representative drugs of targeted therapy and potential therapeutic targets for HCC are reviewed.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Chinese Medical Sciences Journal
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS